Effects of HFNC on Moderate and Severe Respiratory Failure Patients

NCT02687074 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 246

Last updated 2016-02-22

No results posted yet for this study

Summary

Respiratory failure is the danger for the patients admitted in ICU, mechanical ventilation could save a lot of patients' life, however, it prolongs patients' ICU stay and hospital stay. High flow nasal cannula (HFNC) has advantages of PEEP effects, reducing dead space, increasing EELV and improving comfort, and it has been used to treat respiratory failure patients. In recent study, HFNC could improve mortality of respiratory failure patients with P/F\<200mmHg in the subgroup. The investigators want to start a randomized controlled study to evaluate the effects of HFNC on the patients with respiratory failure.

Conditions

Interventions

DEVICE

HFNC

patients treated with high flow nasal cannula

DEVICE

NIV

patients treated with noninvasive ventilation

Sponsors & Collaborators

  • First Affiliated Hospital of Suzhou Medical College

    collaborator OTHER
  • Second Affiliated Hospital of Suzhou University

    collaborator OTHER
  • Zhangjiagang First People's Hospital

    collaborator OTHER
  • The Second Hospital of Nanjing Medical University

    collaborator OTHER
  • Wuxi No. 4 People's Hospital

    collaborator OTHER
  • Southeast University, China

    lead OTHER

Principal Investigators

  • Chun Pan, Dr · Zhongda hospital, Southeast University, Jiangsu, China

  • Fuxi Sun, Dr · Nanjing Medical University affiliated Second Hospital

  • Wei Liu, Dr · Wuxi Hospital

  • Jianfeng Xie, Dr · Suzhou Shili Hospital

  • Songqiao Liu, Dr · Suzhou Sencond Hospital

  • Ling Liu, Dr · Zhangjiagang Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2016-12-31
Completion
2017-12-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02687074 on ClinicalTrials.gov